Humic and Fulvic Acid for Aging

SA
Overseen ByStudy Administrator
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.

Are You a Good Fit for This Trial?

This trial is for generally healthy adults aged 40 or older who can read and speak English. People with serious health conditions or those not meeting these criteria cannot participate.

Inclusion Criteria

I am 40 years old or older.
I can read and speak English.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the BioToxin Binder dietary supplement containing humic and fulvic acid

12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Humic and Fulvic Acid Dietary Supplement

Trial Overview

The study tests a dietary supplement called BioToxin Binder, which contains humic and fulvic acid, to see how it affects markers related to aging, detoxification, inflammation, and oxidative stress in healthy adults.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Humic and Fulvic Acid Dietary SupplementExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

OvationLab

Lead Sponsor

Trials
1
Recruited
150+